Stifel Nicolaus Upgrades Xylem (XYL) to Buy

Go back to Stifel Nicolaus Upgrades Xylem (XYL) to Buy

Wedbush Upgrades Xylem (XYL) to Outperform as Outlook Improves

April 30, 2014 7:14 AM EDT

Wedbush upgraded Xylem (NYSE: XYL) from Neutral to Outperform with a price target of $42.00 (from $38.00). Analyst David L. Rose thinks Q1 results suggest its turnaround has legs.

"Recent results reflect continued progress on the early stages of an operational turn-around. While end markets... More

Xylem, Inc. (XYL) Tops Q1 EPS by 2c

April 29, 2014 7:21 AM EDT

Xylem, Inc. (NYSE: XYL) reported Q1 EPS of $0.34, $0.02 better than the analyst estimate of $0.32. Revenue for the quarter came in at $906 million versus the consensus estimate of $888.9 million.

Xylem, Inc. reaffirmed FY2014 guidance.

For earnings history and earnings-related data on Xylem, Inc. (XYL) click here.

... More